Prospera Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Sell |
35,851
-1,110
| -3% | -$27K | 0.02% | 705 |
|
|
2025
Q1 | $767K | Buy |
36,961
+1,253
| +4% | +$26K | 0.02% | 637 |
|
|
2024
Q4 | $841K | Buy |
35,708
+2,101
| +6% | +$49.5K | 0.02% | 593 |
|
|
2024
Q3 | $860K | Buy |
33,607
+5,180
| +18% | +$133K | 0.02% | 539 |
|
|
2024
Q2 | $667K | Buy |
28,427
+10,556
| +59% | +$248K | 0.02% | 612 |
|
|
2024
Q1 | $514K | Buy |
17,871
+5,734
| +47% | +$165K | 0.02% | 707 |
|
|
2023
Q4 | $398K | Buy |
+12,137
| New | +$398K | 0.01% | 729 |
|
|
2023
Q2 | – | Sell |
-8,644
| Closed | -$260K | – | 1012 |
|
|
2023
Q1 | $260K | Sell |
8,644
-465
| -5% | -$14K | 0.01% | 825 |
|
|
2022
Q4 | $257K | Buy |
9,109
+2,337
| +35% | +$66K | 0.01% | 761 |
|
|
2022
Q3 | $222K | Sell |
6,772
-110
| -2% | -$3.61K | 0.01% | 747 |
|
|
2022
Q2 | $217K | Sell |
6,882
-1,406
| -17% | -$44.3K | 0.01% | 712 |
|
|
2022
Q1 | $381K | Buy |
8,288
+1,208
| +17% | +$55.5K | 0.02% | 674 |
|
|
2021
Q4 | $434K | Sell |
7,080
-128
| -2% | -$7.85K | 0.02% | 610 |
|
|
2021
Q3 | $539K | Buy |
7,208
+980
| +16% | +$73.3K | 0.03% | 512 |
|
|
2021
Q2 | $576K | Buy |
6,228
+2,712
| +77% | +$251K | 0.03% | 495 |
|
|
2021
Q1 | $312K | Buy |
+3,516
| New | +$312K | 0.02% | 606 |
|
|
2020
Q4 | – | Sell |
-200
| Closed | -$13K | – | 728 |
|
|
2020
Q3 | $13K | Buy |
+200
| New | +$13K | 0.01% | 1024 |
|